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Abstract Based on studies with chimeras between (non-)
gastric H,K-ATPase and Na,K-ATPase, a model for the
ouabain binding site has recently been presented (Qiu et al.
J.Biol.Chem. 280 (2005) 32349). In this model, hydrogen
bonds between specific amino acid residues of Na,K-
ATPase and hydroxyl groups of ouabain play a crucial
role. In the present study, a series of ouabain analogues
were tested on baculovirus-expressed Na,K-ATPase and an
ouabain-sensitive mutant of non-gastric H,K-ATPase
(D312E/ S319G/ A778P/ I795L/ F802C). For each ana-
logue, the results obtained by measuring ATPase inhibition
and [3H]ouabain replacement agreed rather well. In Na,K-
ATPase, strophanthidin had a 7–10 times higher and
digoxin a 4–12 times lower affinity than ouabain. The
results of the non-gastric H,K-ATPase mutant were rather
similar to that of Na,K-ATPase with exception of dihydro-
ouabain that showed a much lower affinity with the non-
gastric H,K-ATPase mutant. Docking studies showed that
all analogues bind to the same pocket in Na,K-ATPase.
However, the amino acids to which hydrogen bonds were
formed differed and depended on the availability of
hydroxyl or keto groups in the ouabain analogues.
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Introduction
Na,K-ATPase, gastric H,K-ATPase and non-gastric H,K-
ATPase form within the family of P-type ATPases a special
subfamily (IIc) [1]. Like all other P-type ATPases, its
members have a catalytic subunit (α) with a molecular
mass around 100 kDa. However, the members of this
special subfamily cannot function unless a β-subunit, a
glycoprotein with a protein molecular mass of about
35 kDa, is present. There are four genes that code for the
catalytic subunit of Na,K-ATPase and one for the gastric as
well as one for the non-gastric H,K-ATPase. These catalytic
subunits cross the membrane ten times and are for 60–65%
identical. The phylogenic distance between the catalytic
subunits of Na,K-ATPase, gastric H,K-ATPase and non-
gastric H,K-ATPase is about similar. There are three genes
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that code for β-subunits of Na,K-ATPase (β1–3) and one for
the β-subunit of gastric H,K-ATPase (βHK). The non-
gastric H,K-ATPase has no own β-subunit but most likely
uses the β1-subunit of Na,K-ATPase [2–4]. Both Na,K-
ATPase (α1) and the gastric H,K-ATPase work optimally
with their own subunits (β1 and βHK, respectively), but still
show some activity with each other’s β-subunit [5]. All
ATPases of this family are localised at the plasma
membrane. The gastric H,K-ATPase can be found at the
apical plasma membrane of gastric parietal cells, the non-
gastric H,K-ATPase at apical membranes of kidney, colon
and prostate glands [6]. Na,K-ATPase is present at the
plasma membrane of all mammalian cells. In epithelial
cells, it is mainly present on basolateral plasma membranes.
It is a common property of P-type ATPases that during the
catalytic cycle, they form a phosphorylated intermediate at an
aspartate residue present as part of the sequence DKTP, present
in the intracellular-located P-domain. The members of the IIc
subfamily have in common that K+ stimulates the ATPase
reaction through stimulation of the rate of dephosphorylation
of this phosphorylated intermediate. The latter cation can be
replaced by other monovalent cations like Rb+ and NHþ4 . In
the expressed non-gastric H,K-ATPase, the affinity for NHþ4
is even higher than for K+, and the specific activity with
NHþ4 is much higher than with K
+ [4, 7]. K+ ions and similar
cations can be transported into the cell by these ATPases.
Despite these similarities, there are differences between the
members of this subfamily. Na+ is necessary for the activity of
Na,K-ATPase and does not stimulate gastric H,K-ATPase.
Regarding the non-gastric H,K-ATPase there is disagreement
whether Na+ can activate this ATPase [4, 8, 9]. The gastric H,
K-ATPase activity and, most likely, the non-gastric H,K-
ATPase activity are stimulated by H+. This is performed by
stimulation of the phosphorylation rate of these ATPases. The
stimulations by Na+ and H+, respectively, are accompanied by
transport of these ions out of the cell.
Another difference is the sensitivity for ouabain and other
cardiac glycosides. The Na,K-ATPase of most species is very
sensitive towards ouabain. The affinity of the α1 form of rat
and mouse, however, is about 100 times lower than that of
most other species. Lingrel and co-workers have shown that
this is due to the presence of an Arg on position 111 and an
Asp on position 122 of the catalytic subunits of these
rodents, while in all other ouabain-sensitive species, a Gln
and an Asn, respectively, are present on these positions [10].
The gastric H,K-ATPase is not sensitive towards ouabain
whereas the sensitivity of the non-gastric H,K-ATPase is
even lower than that of rodent Na,K-ATPase, despite the fact
that in both H,K-ATPases, a Gln and an Asn are present on
the positions comparable to positions 111 and 122.
In 2000, we surprisingly showed a high affinity for ouabain
in a chimera that had, as basis, the gastric H,K-ATPase (α and
β subunits) and in which the transmembrane segments M3/
M4 and M5/M6 of the α-subunit were replaced by those of
Na,K-ATPase [11]. This chimera was expressed in insect
cells using the baculovirus expression system. The four
transmembrane segments originating from Na,K-ATPase still
contained 48 amino acids that were specific for this enzyme.
Later, we could reduce this number to seven and still kept a
high affinity for ouabain [12, 13]. In the latter studies, we
used the oocyte expression system and restricted ourselves
to the measurement of ouabain binding. The resulting
chimera (EVIGFTD) had a high affinity for ouabain
binding in the oocyte system. The seven amino acids
Glu312, Val314, Ile315, Gly319 (all from M4), Phe783 (M5),
Thr797 and Asp804 (both from M6) were needed for high-
affinity ouabain binding in the sense that replacing one of
these amino acids by their counterpart from gastric H,K-
ATPase lowered the ouabain binding level considerably.
Despite several trials, however, we were not able to get this
chimera well expressed in the baculovirus expression
system. The latter preparation had a very low ATPase
activity and could not be used for obtaining reliable figures
for ouabain affinity (unpublished results).
In a next study, we succeeded to convert the rat non-
gastric H,K-ATPase that has a very low affinity for ouabain,
by mutation of only five amino acids into an enzyme with a
high affinity for ouabain [14]. Two of these amino acids
(Glu312 and Gly319) were also found to be important in the
study with the gastric H,K-ATPase chimera EVIGFTD,
whereas three others Pro778, Leu795 and Cys802 were new.
This chimera (EGPLC) could, in contrast to chimera
EVIGFTD, well be expressed in the baculovirus system
and showed a high NHþ4 -activated ATPase activity that
could be inhibited by low ouabain concentrations [14].
In the course of the study with the EVIGFTD chimera, a
docking study with ouabain in Na,K-ATPase homologue based
on the 1WPG structure (close to the E2P form of Ca
2+-ATPase)
was performed. The resulting model showed important roles
for several of the amino acids that were identified in both
studies with the chimeras [13, 14]. In addition, the two amino
acids discovered by Lingrel’s group [15] were very important
in the model. They formed hydrogen bonds with hydroxyl
groups coupled to the steroid skeleton of ouabain. Gln111 had
hydrogen bonds with both OH groups on places 1 and 11 of
the steroid skeleton of ouabain, whereas Asn122 had a
hydrogen bridge with the OH on position 11 (see Fig. 1).
Such a model explains, at least qualitatively, the lower affinity
for ouabain of rat and mouse Na,K-ATPase.
There are many heart glycosides that can inhibit Na,K-
ATPase. They differ from ouabain by the absence or type of
sugars, by the functional groups attached to the steroid
skeleton and by the presence of a double bond in the
lactone ring. One would expect that this would lead to large
differences in binding affinities between these analogues.
Moreover, the species difference as observed with ouabain
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would be absent for analogues in which these particular
hydrogen bridges could not be formed. By testing these
analogues on the EGPLC mutant, one could moreover
establish whether or not the binding site for heart glyco-
sides in this mutant is completely similar to that in Na,
K-ATPase. We studied, in addition to ouabain, the
following five analogues: digoxin, dihydro-ouabain,
digoxigenin, strophanthidin and ouabagenin. We used
the baculovirus-expressed rat Na,K-ATPase, the QN
mutant of rat Na,K-ATPase (Arg and Asp on positions
111 and 121 replaced by Gln and Asn, respectively), the
rat non-gastric H,K-ATPase and its EGPLC mutant. We
determined the affinity of these compounds in two
different ways. We measured their inhibitory potency in
ATPase assays (for Na,K-ATPase and its QN mutant with
both Na+ and K+ as activating ions and for non-gastric H,
K-ATPase and the EGPLC mutant with NHþ4 as activating
ion). In addition, we determined the apparent affinity for
these compounds when they competed with [3H]-ouabain
for the binding to these constructs.
Materials and methods
Construction of recombinant Na,K-ATPase and non-gastric
H,K-ATPase
The chimeras and mutants used in this study were: the rat
Na,K-ATPase α1-subunit (wild type), the R111Q/ D122N
mutant (QN) of this enzyme [10, 11], the rat non-gastric H,
K-ATPase α2-subunit [13] as well as its EGPLC mutant
(D312E, S319G, A778P, I795L, F802C) [14]. Generation
of the vectors containing the α2-subunit of rat non-gastric
H,K-ATPase with the β1-subunit of rat Na,K-ATPase or the
α1-subunit of rat Na,K-ATPase with the β1-subunit of
sheep Na,K-ATPase that were suited for the baculovirus
expression system, has been reported before [5, 14].
Preparation of Sf 9 membranes
Sf 9 cells were grown at 27°C in 100-ml spinner flask
cultures as described by Klaassen et al. [16]. For expression
of the ATPases, 1.5.106 cells.ml−1 were infected with the
proper virus at a multiplicity of infection of 1–3 in the
presence of 1% (v/v) ethanol and 0.1% (w/v) pluronic F-68
(ICN, Aurora, OH, USA) in Xpress medium (Biowittaker,
Walkersville, MD, USA) as described before [17]. After
3 days, Sf 9 cells were harvested by centrifugation at
2,000×g for 5 min. The cells were washed once at 0°C with
0.25 M sucrose, 2 mM EDTA and 25 mM Hepes/Tris (pH
7.0), resuspended in sucrose/EDTA/Tris buffer and sonicated
at 60 W (Branson Power Company, Denbury, CT, USA) for
30 s at 0°C. After centrifugation for 30 min at 10,000×g the
supernatant was collected and recentrifuged for 60 min at
100,000×g at 4°C. The pelleted membranes were resus-
pended in the above-mentioned buffer and stored at −20°C.
Biochemical methods
Protein determination The protein concentrations were
quantified with the modified Lowry method according to
Peterson [18] using bovine serum albumin as a standard.
Fig. 1 Chemical structure of the
ouabain analogues
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[3H]Ouabain binding Sf 9 membranes (±100 μg) were
incubated at room temperature in 50 mM Tris-acetic acid
(pH 7.0), 1 mM ATP, 5.0 mM MgCl2, 25 nM [
3H]ouabain,
1 mM H3PO4 at a final volume of 50 μl in the presence of
the concentrations of ouabain or its analogues as indicated.
After 2 h, the reaction mixture was chilled for 15 min on ice.
The ouabain-protein complex was collected by filtration over
a 0.8-μm membrane filter (Schleicher and Schuell, Dassel,
Germany). After washing twice with ice-cold water, radio-
activity was analysed by liquid scintillation analysis.
ATPase assay The ATPase activity was determined using a
radiochemical method [19]. For this purpose, 10–30 μg of
Sf 9 membranes were added to 100 μl of medium
containing 2 mM Mg-[γ-32P]-ATP, 10 mM NH4Cl (non-
gastric H,K-ATPase or its EGPLC mutant), 100 mM NaCl
and 10 mM KCl (Na,K-ATPase wild type and its QN
mutant), 0.8 mM MgCl2, 0.1 mM EGTA, 0.2 mM EDTA,
1 mM TrisN3, 50 mM Tris-HCl (pH 7.0) and concentrations
of ouabain or its analogues as indicated. After incubation
for 60 min at 37°C, the reaction was stopped by adding
500 μl 10% (w/v) charcoal in 6% (v/v) trichloroacetic acid
and after 10 min at 0°C, the mixture was centrifuged for
10 s at 10,000×g. To 0.15 ml of the clear supernatant,
containing the liberated inorganic phosphate (32Pi), 3 ml
OptiFluor (Canberra Packard, Tilburg, The Netherlands)
was added and the mixture was analysed by liquid
scintillation analysis. In general, blanks were prepared by
incubating in the absence of membranes. ATPase activity is
presented as the difference in activity between membranes
of ATPase-expressing cells and mock-infected cells.
Docking of ouabain
The homology model of the QN mutant of rat Na,K-ATPase
[13], based on an E2-P-like structure of Ca
2+-ATPase
(1WPG; [20]), was used for in silico docking with the
FlexX program [21], version 1.13.5 L. FlexX predicts the
conformations of a set of energetically favourable molecular
complexes consisting of the ligand bound to the active site of
the protein. The complexes were labelled with a score that
approximates binding energy. Because of the huge size of
the ATPase model, placement of the ligand was restricted to
the previously postulated binding pocket on the extra-
cellular side of the membrane [12]. Besides an overall
pocket, a sub-pocket was defined to include residues known
from mutation experiments to be important for ligand
binding. The use of a sub-pocket lets FlexX place the base
fragment (the first placed fragment of the ligand) near one of
the residues in the sub-pocket. The rest of the ligand still has
the freedom to completely move away from these residues as
long as the ligand remains within the overall pocket.
The starting structure for ouabain and its analogues was
obtained from the Cambridge Structural Database [22].
Hydrogens were added interactively with Molden package
[23]. Molden was also used to assign the atom types of the
Sybyl force field. This assignment was checked by visual
inspection. Bond lengths and bond angles were optimised
with the Sybyl force field.
FlexX produced a number of protein-ligand complexes,
of which the ten best scoring ones were inspected visually.
These so-called poses showed little variation in geometries.
The best scoring pose was used for this work. As FlexX
keeps the protein completely fixed, the amino acid side-
chain rotamers could not be expected to be optimal, as the
homology model was built in absence of ouabain. Conse-
quently, the best scoring pose was subjected to an
additional energy minimization with the Yamber force field
[24, 25], which resulted in improved hydrogen bonding
patterns.
Calculations
IC50 values were determined by analysing the plots using
the non-linear curve-fitting program (Hill equation func-
tion) of Orgin 6.1 (OriginLab Corp., Northampton, MA,
USA). Data are presented as mean values with standard
error of the mean of the number experiments. Differences
were tested for significance by means of Student’s t test.
Materials
Ouabain (O3125), ouabagenin (O2627), digoxigenin
(D9026), dihydro-ouabain (D0670), digoxin (D6003) and
strophanthidin (S6626) were from Sigma-Aldrich, St.
Louis, MO, USA [3H]Ouabain (17 Ci mmol−1) and
[γ-32P]ATP (3000 Ci mmol−1) were purchased from
Amersham Pharmacia (Buckinghamshire, United Kingdom).
Results
ATPase inhibition studies
The five ouabain analogues (structures given in Fig. 1)
were chosen to get a series of analogues with limited
differences as compared to ouabain. Whereas ouabain has a
rhamnose sugar coupled to the OH group on position 3 of
the steroid skeleton, ouabagenin lacks this sugar. In
dihydro-ouabain, the lactone ring is saturated. Strophanthidin
lacks, like ouabagenin, not only the rhamnose sugar but
also the two hydroxyl groups that in ouabain are coupled to
the steroid on positions 1 and 11. In addition, a keto group
replaces the hydroxyl group on position 19. In digoxin, the
rhamnose from ouabain is replaced by trisdigitoxose.
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Digoxin also lacks the OH groups on positions 1, 5, 11 and
19 of the steroid skeleton and has an additional OH group
on position 12. Digoxigenin is similar to digoxin but lacks
the sugar chain.
Figure 2 shows that all ouabain analogues only inhibit
the Na,K-ATPase activity of the rat wild-type enzyme when
very high concentrations were applied. Much lower con-
centrations were needed when the QN analogue of Na,K-
ATPase was used. This means that the presence of an Arg
on position 111 and an Asp on position 122 in the rat wild-
type enzyme not only lowers the affinity for ouabain but
also for the five studied analogues. Table 1 gives the IC50
values, both absolutely (line A) and relative to the value
with ouabain (line B). The Table shows that the IC50 value
for strophanthidin is lower than for ouabain. The IC50
values for digoxin and ouabagenin are higher than that of
ouabain, whereas those of dihydro-ouabain and digoxigenin
do not significantly differ with that of ouabain.
Figure 3 shows that the wild-type non-gastric H,K-
ATPase activity was very insensitive to ouabain and its
analogues. Due to the limited solubility of some of these
analogues, it is impossible to measure IC50 values for this
inhibition. The NHþ4 -stimulated ATPase activity of the
EGPLC mutant, on the other hand, could be inhibited by
low concentrations of all analogues. Compared to ouabain,
both strophanthidin and digoxin had slightly lower IC50
values, whereas these values for digoxigenin and ouabage-
nin were two and eight times higher, respectively. The IC50
value for dihydro-ouabain was more than 40 times higher
than that for ouabain.
Fig. 2 Inhibition of the Na+-
and K+-activated ATPase activi-
ty of Na,K-ATPase (closed
symbols) and its QN-mutant
(open symbols) by ouabain and
five of its analogues
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Comparison of the IC50 values for ouabain and its
analogues on the ATPase activity of Na,K-ATPase (QN)
and the EGPLC mutant of non-gastric ATPase (line C)
shows that ouabain inhibited both enzymes equally potent-
ly. Remarkably, the ATPase activity of the EGPLC mutant
was even relatively better inhibited by digoxin than by
ouabain, whereas it was much less inhibited by dihydro-
ouabain. Strophanthidin, ouabagenin and digoxigenin
inhibited the activity of the EGPLC mutant about three
times less than that of Na,K-ATPase (QN).
[3H]ouabain replacement studies
Because of the very low affinity for ouabain of the
unmodified rat Na,K-ATPase and the rat non-gastric H,K-
ATPase, [3H]ouabain replacement studies could only be
carried out with the QN-analogue of Na,K-ATPase and the
EGPLC mutant of non-gastric H,K-ATPase. Figure 4 shows
that all analogues are able to displace [3H]ouabain, either
when bound to the Na,K-ATPase (QN) or to the EGPLC
mutant of non-gastric H,K-ATPase. The IC50 values for
these replacements are presented in Table 1, both as
absolute values (line D) and relative to the IC50 value for
ouabain (line E). When the QN mutant of Na,K-ATPase
was used strophanthidin, digoxigenin and ouabagenin had a
two- to tenfold lower IC50 value than ouabain. Digoxin,
however, had an 11 times higher IC50 value. The IC50 value
for dihydro-ouabain was slightly higher than that of
ouabain.
When [3H]ouabain replacement studies were carried out
with the EGPLC mutant of non-gastric H,K-ATPase,
strophanthidin had a two times lower IC50 value than
ouabain. The IC50 values for both digoxin and digoxigenin
were about twice as high and that of ouabagenin was about
nine times as high as that of ouabain. The IC50 value for
dihydro-ouabain was more than 80 times as high as that of
ouabain.
As is clear from both Fig. 4 and line F from Table 1, the
EGPLC mutant binds digoxin relatively better than the QN
mutant of Na,K-ATPase. The EGPLC mutant binds
digoxigenin, strophanthidin and ouabagenin with a five to
ten times relative lower affinity than Na,K-ATPase. The
EGPLC mutant has a very low affinity for dihydro-ouabain.
Comparison of both methods
The results presented in lines B and E of Table 1 are
graphically presented in Fig. 5. Both for the QN mutant of
Na,K-ATPase (Fig. 5a) and the EGPLC mutant of non
gastric H,K-ATPase (Fig. 5b), there is a very good
correlation between the results of the ATPase inhibition
and the [3H]ouabain replacement experiments. This indi-
cates that the IC50 values for a single compound and
ATPase preparation, obtained by measuring the effects on
ATPase inhibition and ouabain replacement, are within a
narrow range.
Docking experiments
Similarly, as described earlier for ouabain [13], docking
experiments were carried out with the five analogues in a
homology model of the E2-P form of human Na,K-ATPase,
based on the 1WPG structure of Ca2+-ATPase. The human
ATPase is comparable to the QN mutant. Although all
Table 1 The effect of the ouabain analogs in ATPase activity measurements and [3H]-ouabain displacement studies
n ouabain digoxin dihydro-ouabain digoxigenin strophanthidin ouabagenin
ATPase activity measurements
A. IC50 values (μM) Na,K-ATPase (wt) 2 60±2 20±2 >1000 >100 160±20 >1000
Na,K-ATPase (QN) 3–4 0.11±0.024 0.48±0.227 0.11±0.010 0.08±0.031 0.02±0.002* 0.23±0.023
HKα2-ATPase (wt) 3 >200 >100 >1000 >100 >1000 >500
EGPLC mutant 4 0.10±0.005 0.07±0.010* 4.7±0.75* 0.20±0.048 0.05±0.005* 0.80±0.246
B. Relative to ouabain Na,K-ATPase (QN) 1.00±0.300 4.2±2.20* 1.01±0.232 0.66±0.308 0.14±0.035* 2.0±0.47*
EGPLC mutant 1.00±0.070 0.65±0.104 46±7.8* 2.0 ± 0.49 0.48±0.055* 7.9±2.47*
C. Relative to Na,K-ATPase (QN) 1.00±0.308 0.15±0.083 45.8±13.05 3.0±1.6 3.4±0.91 3.9±1.53
Ouabain replacement studies
D. IC50 values (μM) Na,K-ATPase (QN) 4 0.07±0.006 0.78±0.252* 0.08±0.002* 0.02±0.005* 0.01±0.002* 0.05±0.019
EGPLC mutant 4 0.31±0.040 0.76±0.214 27±3.2* 0.75±0.268 0.17±0.032* 2.8±1.31
E. Relative to ouabain NaK-ATPase (QN) 1.00±0.127 11.6±3.90* 1.21±0.112 0.25±0.078* 0.10±0.031* 0.70±0.290
EGPLC mutant 1.00±0.181 2.4±0.75* 86±15.0* 2.4±0.91* 0.54±0.124 8.9±4.33*
F. Relative to Na,K-ATPase (QN) 1.00±0.221 0.21±0.095 71±14.1 9.5±4.62 5.2±1.95 12.8±8.12
Data from Figs. 2, 3 and 4
A and D inhibition data (IC50 values) in µM, B and E IC50 values relative to ouabain, C and F data from B and E relative to Na,K-ATPase (QN;
relative ratio EGPLC/Na,K-ATPase (QN)
*P<0.05
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analogues bound in the same pocket as ouabain, they
interacted in part with different amino acid residues. As an
example, the binding of strophanthidin is presented in
Fig. 6. Table 2 gives a summary of the hydrogen bridges
with Na,K-ATPase that were found for the various ouabain
analogues. All analogues, except digoxin, form one or more
hydrogen bridges from hydroxyl groups bound to the
steroid skeleton with Gln111. The latter residue forms
normally a hydrogen bridge with Asn122. This hydrogen
bridge is broken when these analogues are present. Only
with digoxin does a binding with Gln111 not occur and the
hydrogen bridge with Asn122 stays intact. Most analogues
also form hydrogen bridges with Arg972. This residue forms
normally a salt bridge with Glu908. With ouabain and
dihydro-ouabain, this salt bridge is still intact but with
digoxin, digoxigenin, strophanthidin and ouabagenin, the
binding energy of the complex between drug and Na,K-
ATPase is apparently sufficient to open this salt bridge.
Table 2 also shows that in case sugars are present, they
always couple to Glu312 with one or more hydrogen
bridges. In most cases, the lactone ring binds to the three
adjacent amino acid residues Thr797, Val798 and Thr799, in
part, through an interaction with the backbone amide
groups. There is no clear hydrogen bonding of the lactone
ring in dihydro-ouabain because of a different orientation of
this ring.
Docking experiments were also carried out with the rat
wild-type Na,K-ATPase; Arg111 of the wild type is more
bulky than Gln111 of the QN mutant. Only two of the
possible rotamers of Arg111 do not substantially decrease
the space available for the ligands. Both rotamers form a
salt bridge with Asp122 but, in addition, offer interaction
Fig. 3 Inhibition of the NHþ4 -
activated ATPase activity of
non-gastric H,K-ATPase (open
symbols) and its EGPLC mutant
(closed symbols) by ouabain and
five of its analogues
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Fig. 4 [3H]ouabain displace-
ment experiments of Na,K-
ATPase (QN; open symbols) and
the non-gastric H,K-ATPase
EGPLC mutant (closed symbols)
in the presence of Pi
Fig. 5 Correlation between the
IC50 values obtained by mea-
suring the inhibition of the
ATPase activity and the dis-
placement of [3H]ouabain bind-
ing by the ouabain analogues in
Na,K-ATPase (QN) and H,K-
ATPase EGPLC. The reciprocal
value of the IC50 value obtained
with ouabain was set at 1 and all
other values were related to this
value
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sites for the ligands. Of these two rotamers, only one yields
successful docking results for more than one ligand. With
exception of strophanthidin, these docking poses are
different from that with the QN mutant.
Discussion
Two methods were used in this study to determine the
apparent affinities for some ouabain analogues. On the one
hand, the ability to compete with [3H]ouabain for the
binding to several ATPases and on the other hand, the
inhibitory effect on the activities of these ATPases. Because
of the very low binding level of [3H]ouabain to wild-type
rat Na,K-ATPase and rat non-gastric H,K-ATPase, the
ouabain replacement method could not be used with these
preparations. Only with the QN mutant of rat Na,K-ATPase
and the EGPLC mutant of non-gastric H,K-ATPase was the
use of both methods possible. Although the results between
the QN mutant and the EGPLC mutant for the various
analogues differ, the IC50 values obtained with both
methods (ATPase inhibition measurements and [3H]ouabain
replacement studies) are, in general, rather similar for a
single drug used with one of both ATPases. Our findings
for Na,K-ATPase (QN) contrast with those of Paula et al.
[26] who carried out apparently similar studies on lamb
kidney ATPase (that also contains a Gln on position 111
and an Asn on position 122) with a very large series of
Fig. 6 Molecular model of docking of strophanthidin in Na,K-
ATPase. Nitrogen is colored blue, oxygen red and carbon cyan or
green (in strophanthidin). Hydrogen bonds are shown as yellow dotted
lines. Surrounding parts of the structure have been hidden for clarity.
Amino acids that were shown to be essential for ouabain binding [13,
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ouabain analogues. Whereas their results on Na,K-ATPase
inhibition, with exception of those for strophanthidin, fit
reasonably well with our findings, Paula et al. [26] found
for all inhibitors, except digoxin, much higher IC50 values
in ouabain replacement studies than we found in the present
study (Table 3). An explanation for this discrepancy cannot
yet be given. A good correlation between [3H]ouabain
replacement and ATPase inhibition, as found by us, is what
would be expected.
For the wild-type rat Na,K-ATPase, only ATPase
inhibition measurements could be carried out. As shown
in Fig. 3 and Table 1, the IC50 values were very high and
only a lower limit of the IC50 values for dihydro-ouabain,
digoxigenin and ouabagenin could be given. However, it is
clear that the difference in IC50 value for ouabain between
the wild-type enzyme and the QN mutant is valid not only
for ouabain but also for all the other tested analogues. In
our published model for the ouabain-binding site [13], the
hydrogen bridges between Gln111 and Asn122 at the one
side and the hydroxyl groups on positions 1 and 11 of the
steroid skeleton at the other side play an essential role.
Because some or all of these hydroxyl groups are absent or
are located on different positions in the analogues, there
must be another explanation for the low affinity of all these
inhibitors for the rat wild-type Na,K-ATPase. It might be
that the charged residues at the positions 111 and 122 in
rodent species prohibit the entrance of these compounds to
the binding pocket. The docking experiments suggest that,
in particular, the (bulky) Arg residue on position 111
occupies part of the binding pocket and so prevents binding
of ouabain and its analogues. It might also be that Arg111
and Asp122 form a salt bridge that is difficult to break.
There is general agreement that ouabain binds to Na,K-
ATPase at the extracellular surface of the α-subunit in the
groove between transmembrane segments 1, 2, 4, 5 and 6
and their extracellular loops. In our published model of a
QN type Na,K-ATPase [13], the rhamnose unit is directed
to the extracellular space, whereas the lactone ring is
oriented deeply into the membrane. A similar model is
postulated by Munson et al. [27], although, in part, other
amino acid residues found by us are close to the ouabain
molecule. Especially, the lactone ring is positioned deeper
in the binding pocket, which is due to relaxation of the
model during the docking experiment. In our opinion, both
docking models are plausible. Keenan et al. [28] have
postulated a model in which the lactone ring is located
close to the extracellular space and the rhamnose is
embedded deeply into the membrane. The latter orientation
does not fit with earlier nuclear magnetic resonance studies
showing that the rhamnose has a high mobility [29].
Glu312 is a residue that, in the models of both Qiu et al.
[13, 14] and Munson et al. [27], forms a hydrogen bridge
with the rhamnose. In gastric H,K-ATPase, this residue is
an Arg, whereas in non-gastric H,K-ATPase, it is an Asp.
The presence of a Glu on this position was shown to be
necessary for high-affinity ouabain binding in both H,K-
ATPases [13, 14]. The binding affinity of ouabain in mutant
E312R of human Na,K-ATPase [30] was much lower than
that of wild-type enzyme. However, there was no difference
in binding affinity when the binding of the sugarless
ouabagenin was measured. This strongly supports the
models with the rhamnose residue at the extracellular
border of the membrane. In our QN rat model, Glu312
always plays a crucial role in sugar binding, also with
digoxin where a large tridigitoxose is present.
Docking experiments with the ouabain analogues in the
Na,K-ATPase (QN) model gave rather variable results.
Although they all bound to the enzyme within the same
pocket, they bound in part to different residues due to
presence or absence of a sugar residue and to the different
groups present at the steroid skeleton. This led to
unexpected changes in binding parameters. One could
expect that ouabagenin would have a much lower affinity
than ouabain because the sugar that binds with several
hydrogen bonds to Na,K-ATPase is absent in ouabagenin.
The biochemical studies show a roughly similar affinity for
ouabain and ouabagenin for the QN mutant of Na,K-
ATPase. Radkov et al. [30] even found a twofold lower Ki
value for ouabagenin than for ouabain. In the docking
experiment, ouabagenin penetrated the membrane more
deeply, resulting in hydrogen bridges of the lactone ring
with residues of M8. Even more striking is our finding that
the apparent affinity for digoxigenin in Na,K-ATPase (QN)
is 6–35 times higher than that of digoxin. It might be that
the absence of the long hydrophilic trisdigitoxose gives this
genin also the chance to penetrate more deeply into the
membrane and form hydrogen bridges that could not occur
when the sugar is present in the molecule. A deeper
penetration into the membrane might also explain the
Table 3 Comparison between the relative IC50 values for a series of
ouabain analogues
Relative IC50 values
[3H]ouabain replacement Na,K-ATPase inhibition
This study [26] This study [26]
Ouabain 1 1 1 1
Digoxin 11.6 2.1 4.2 2.1
Dihydro-ouabain 1.2 22.9 1.0 2.4
Digoxigenin 0.25 11.1 0.66 0.8
Strophanthidin 0.10 10.4 0.14 1.42
Ouabagenin 0.70 311 2.0 2.2
Ouabain analogues are obtained in the present study and by Paula et
al. [26]
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relatively high affinity of Na,K-ATPase (QN) for strophan-
thidin and ouabagenin.
The wild-type non-gastric H,K-ATPase has a very low
affinity for ouabain and the five tested analogues. By
mutation of only five residues resulting in the mutant
EGPLC, it was possible to obtain a high affinity for
ouabain. In the oocyte system, it had a similar affinity
for ouabain as the QN-mutant of Na,K-ATPase [14]. In
the present study using baculovirus expressed enzymes, it
had in the [3H]ouabain replacement studies four times
lower apparent affinity than the Na,K-ATPase (QN)
whereas in the ATPase inhibition studies, the apparent
affinities were similar (Table 1). The EGPLC mutant had
in both assays a 5–6 times higher affinity for digoxin
than for ouabain compared to Na,K-ATPase (QN). The
apparent affinity for digoxigenin, strophanthidin and
ouabagenin was a factor 3–13 (depending on compound
and assay method) lower than for ouabain. Strikingly, the
apparent affinity for dihydro-ouabain in the EGPLC
mutant was much higher (46 times in the ATPase assay
and 86 times in the ouabain replacement studies) than for
Na,K-ATPase. The only difference between dihydro-
ouabain and ouabain is the absence of a double bond
in the lactone ring of the former compound. This absence
leads to another orientation of the lactone ring with
respect to the steroid skeleton. It is likely that in the
binding pocket of Na,K-ATPase, there is enough space
for both orientations, whereas this is not the case in the
EGPLC mutant. The catalytic subunits of Na,K-ATPase
and the EGPLC mutant of non-gastric H,K-ATPase are
only for 60% similar. The EGPLC mutant of non-gastric
H,K-ATPase has only mutations in M4, M5 and M6,
which was sufficient for obtaining a high-affinity for
ouabain. It might be that one or more residues outside
M4–M6 stick into the binding pocket without effect on
the binding of ouabain but hampering the binding of
dihydro-ouabain by occupying the position of the
differently oriented lactone ring.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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